about
Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.Acute phase reactants as novel predictors of cardiovascular disease.Treatment and monitoring of coagulation abnormalities in children undergoing heart surgery.The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies.Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.Preparation of a purified fibrinogen calibration material for Clauss method and turbidimetric immunoassay possessing biological activity and antigenicity.A new method of purifying fibrinogen with both biological and immunological activity from human plasma.Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo.Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction.Direct comparisons of three alternative plasma fibrinogen assays with the von Clauss assay in prediction of cardiovascular disease and all-causes mortality: the Scottish Heart Health Extended Cohort.A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients.Expression of coagulation factors and their receptors in tumor tissue and coagulation factor upregulation in peripheral blood of patients with cerebral carcinoma metastases.The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial.
P2860
Q33793633-E1408F3B-3DC7-472C-8487-EEB628020179Q37156874-57330FF1-1790-41AD-8CC3-0F3CF41339F1Q37813802-32227694-1DA3-4EB3-9082-502DEFF3E15BQ40866572-DB77629D-C807-4EAB-9F75-0D0B0D4C2945Q43538777-583FF028-5FFE-48C8-9023-26A3341ED0BCQ44446897-814113E0-B2D6-4FA0-85DA-3E41605D65C7Q44647915-1F3461D4-1735-4F47-BA63-B7C35097A1DBQ47322302-FACE80C6-A100-4E39-BD29-28742AE93968Q47373856-F6D78878-ABF3-40A2-9C8E-7A9AACB80D2DQ50967844-80B07814-81DC-4EC6-810A-9D432E0E0B34Q53158248-2B14C687-96AA-4FEC-A430-2D29A30977B5Q53747238-C8A2CE52-B7FA-413F-94DF-934DDBDFF17AQ54981842-E06F09A2-807C-4C5A-9FB9-040845E542E7
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Biochemistry and measurement of fibrinogen.
@en
type
label
Biochemistry and measurement of fibrinogen.
@en
prefLabel
Biochemistry and measurement of fibrinogen.
@en
P356
P1476
Biochemistry and measurement of fibrinogen.
@en
P2093
Nieuwenhuizen W
P304
6-10; discussion 10
P356
10.1093/EURHEARTJ/16.SUPPL_A.6
P478
16 Suppl A
P577
1995-03-01T00:00:00Z